Esperion Therapeutics, Inc. short interest in 2025
In 2025, Esperion Therapeutics, Inc.'s disclosed short interest ran from 17.24% of shares outstanding on 15 Jan 2025 to 14.19% on 31 Dec 2025, a change of -3.05 percentage points. The year's high was 17.24% on 15 Jan 2025 and its low 10.44% on 14 Nov 2025, averaging 13.15% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.49 days on 28 Feb 2025. Full history: Esperion Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 17.24% (15 Jan 2025)
- End of year
- 14.19% (31 Dec 2025)
- Change
- -3.05 pp
- High
- 17.24% (15 Jan 2025)
- Low
- 10.44% (14 Nov 2025)
- Average
- 13.15%
- Highest days to cover
- 11.49 (28 Feb 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 17.24% | 6.98 | |
| 31 Jan 2025 | 15.86% | 5.71 | results (8-K) |
| 14 Feb 2025 | 14.26% | 9.82 | |
| 28 Feb 2025 | 14.73% | 11.49 | |
| 14 Mar 2025 | 14.61% | 5.33 | results (8-K), 10-K filed |
| 31 Mar 2025 | 14.16% | 7.34 | |
| 15 Apr 2025 | 15.18% | 4.39 | |
| 30 Apr 2025 | 15.09% | 6.57 | |
| 15 May 2025 | 14.10% | 3.88 | results (8-K), 10-Q filed |
| 30 May 2025 | 13.29% | 5.50 | |
| 13 Jun 2025 | 12.17% | 5.98 | |
| 30 Jun 2025 | 12.12% | 8.27 | |
| 15 Jul 2025 | 11.15% | 6.98 | |
| 31 Jul 2025 | 11.67% | 3.57 | |
| 15 Aug 2025 | 11.23% | 3.89 | results (8-K), 10-Q filed |
| 29 Aug 2025 | 11.08% | 4.81 | |
| 15 Sep 2025 | 12.30% | 3.34 | |
| 30 Sep 2025 | 13.74% | 4.18 | |
| 15 Oct 2025 | 12.11% | 2.37 | |
| 31 Oct 2025 | 10.84% | 5.31 | |
| 14 Nov 2025 | 10.44% | 3.56 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 12.02% | 3.66 | |
| 15 Dec 2025 | 12.06% | 5.44 | |
| 31 Dec 2025 | 14.19% | 6.92 |
See also: Esperion Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.